Facilitating enhanced 3D visualization of skeletal anatomy, the BoneEnhance machine learning module reportedly provides automated segmentation of bone and surrounding tissues for the Accuro XV ultrasound system.
|Articles|January 11, 2012
FDA Clears Siemens' New Ultrasound System
Author(s)Diagnostic Imaging Staff
Siemens Healthcare’s latest release of the ACUSON SC2000 volume imaging ultrasound system has received FDA 510(k) clearance, the company announced.
Advertisement
Siemens Healthcare’s latest release of the ACUSON SC2000 volume imaging ultrasound system has received FDA 510(k) clearance, the company announced.
The Release 2.0 of the company’s echocardiography system is now commercially available in the U.S., and is the first ultrasound system that enables production of real-time, full-volumetric cardiac images in one heart cycle, the company said.
New applications aimed at providing performance and imaging enhancements to improve workflow and patient outcomes include the quantification of the 3-D proximal isovelocity surface area (PISA) to assess the severity of valvular disease and volumetric color Doppler.
It also includes a comprehensive package for automated left ventricle analysis and Siemens’ IN Focus coherent image-forming technology, which processes information at 2.88 gigabytes per second, making it the fastest echocardiography system, according to the company. This allows users to focus on the entire field of view, revealing more detailed information in one image.
Release 2.0 supports volumetric intracardiac echocardiography, which enables the integration of the ACUSON AcuNav ultrasound catheters, the company said. Electrophysiologists and interventional cardiologists can obtain ultrasound images from within the heart in real time, the company said.
Advertisement
Related to this article
A Kaiser score > 5 with breast MRI demonstrated a 97 percent sensitivity and 87.9 percent specificity for predicting malignancy in patients with BI-RADS 0 or 4 presentations on mammography and breast ultrasound, according to a new study.
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.
Catch up on the top radiology content of the past week.
For patients with hepatocellular carcinoma (HCC), perfusion beyond tumor margin on contrast-enhanced ultrasound that exceeds gray-scale ultrasound tumor measurement by 5 mm is associated with a 76 percent higher risk of worse recurrence-free survival, according to newly published research.
In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.
Catch up on the top radiology content of the past week.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Diagnostic Imaging's Weekly Scan: October 18 — October 24
2
FDA Clears Machine Learning Module for Emerging Musculoskeletal Ultrasound Platform
3
Study Shows PCCT Offers Higher Image Quality and Reduced Radiation Dosing than EID-CT in Obese Patients
4
Can MRI-Based AI Have an Impact in Reducing Unnecessary Prostate Biopsies?
5